Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002143
UniProt IDP15259
Primary gene name(s)PGAM2
Synonym gene name(s)PGAMM
Protein namePhosphoglycerate mutase 2
Protein functionInterconversion of 3- and 2-phosphoglycerate with 2,3-bisphosphoglycerate as the primer of the reaction. Can also catalyze the reaction of EC, synthase, but with a reduced activity.
Subcellular locationunknown
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P15259
Gene Ontology
(Biological Process)
Complete annatation
canonical glycolysis [GO:0061621];
gluconeogenesis [GO:0006094];
glycolytic process [GO:0006096];
Notch signaling pathway [GO:0007219];
regulation of pentose-phosphate shunt [GO:0043456];
response to mercury ion [GO:0046689];
spermatogenesis [GO:0007283];
striated muscle contraction [GO:0006941]
Gene Ontology
(Molecular Function)
Complete annatation
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538];
bisphosphoglycerate 2-phosphatase activity [GO:0004083];
bisphosphoglycerate mutase activity [GO:0004082];
cofactor binding [GO:0048037];
phosphoglycerate mutase activity [GO:0004619]
Gene Ontology
(Cellular Component)
Complete annatation
cytosol [GO:0005829];
extracellular exosome [GO:0070062];
nucleus [GO:0005634]
Protein-protein interaction111245
Phylogenetic treeP15259
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-2.858841225175713.94129173741931e-141.16935332807842e-12
AZA vs. DISU0.141544105369870.597780322461460.955158276076142
AZA vs. IL7-0.326541911010710.1311457680737130.897328354403451
AZA vs. SAHA0.5524431538767650.03307644818277390.210555059082404
DISU vs. CD32.989184173490364.31432667369336e-131.65188748184958e-11
DISU vs. IL7-0.4809928260871660.07329064012678230.359859285192052
DISU vs. SAHA0.4126962903436640.1718893017635940.535015214142736
DMSO vs. AZA0.1917114831410240.3163588715846041
DMSO vs. CD33.03671472160612.22044604925031e-168.06048668239903e-15
DMSO vs. DISU0.04735886530452640.8542641068704620.983596648788386
DMSO vs. IL7-0.5095363380028580.01159251821131950.226076600304839
DMSO vs. SAHA0.3565280815567950.1517340985478140.469855064560119
HIV vs. Mock in Activationunknownunknownunknown
HIV vs. Mock in Latency-0.04887539012668620.7871294704930690.999834320637052
IL7 vs. CD32.533345512717677.61313234676209e-121.92215651361382e-10
SAHA vs. CD33.388413414116561.11022302462516e-166.17382324025871e-15
SAHA vs. IL70.8781192964535490.0007394528911210950.0092733052252574
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.0801709 0.889079
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

Drugbank ID Drug Name Drug Status Pharmacological Action Drug Action
DB01681 Benzene Hexacarboxylic Acid experimental unknown unknown
DB04510 3-Phosphoglyceric Acid experimental unknown unknown

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00010 Glycolysis / Gluconeogenesis - Homo sapiens (human)
hsa00260 Glycine# serine and threonine metabolism - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa01200 Carbon metabolism - Homo sapiens (human)
hsa01230 Biosynthesis of amino acids - Homo sapiens (human)
hsa04922 Glucagon signaling pathway - Homo sapiens (human)
hsa05230 Central carbon metabolism in cancer - Homo sapiens (human)